What does DermaSensor do?
DermaSensor develops an FDA-cleared, handheld AI-and-spectroscopy device that helps primary care physicians assess suspicious skin lesions for skin cancer risk at the point of care. The company is expanding US distribution through partnerships with Henry Schein and other healthcare and federal health system partners.